With 0.6 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.46 million shares. The 52-week range on DCTH shows that it touched its highest point at $17.15 and its lowest point at $6.33 during that stretch. It currently has a 1-year price target of $23.57. Beta for the stock currently stands at 0.99.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DCTH was up-trending over the past week, with a rise of 25.26%, but this was up by 55.63% over a month. Three-month performance surged to 10.57% while six-month performance rose 92.35%. The stock gained 151.74% in the past year, while it has gained 50.33% so far this year. A look at the trailing 12-month EPS for DCTH yields -0.51 with Next year EPS estimates of 0.63. For the next quarter, that number is 0.01. This implies an EPS growth rate of 101.54% for this year and 4339.91% for next year.
Float and Shares Shorts:
At present, 33.44 million DCTH shares are outstanding with a float of 29.38 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DCTH since 7 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.66583 being high and -$0.88125 being low. For DCTH, this leads to a yearly average estimate of -$0.77354.
